Streetbeat News

Stock Prices

MU

NVDA

SMH

SOXQ

SOXX

TSM

China is reviving its 'Thousand Talents Plan' (TTP) under a new name, Qiming, to attract top scientists and accelerate its semiconductor industry. This move comes in response to stricter U.S. export controls. The program offers substantial signing bonuses and other incentives. Major industry players like Nvidia Corp, Taiwan Semiconductor Mfg. Co. Ltd., and Micron Technology Inc have already adjusted their strategies in response to U.S. regulations. The broader semiconductor sector, represented by iShares Semiconductor ETF, Invesco PHLX Semiconductor ETF, and VanEck Semiconductor ETF, could also be impacted.

Portfolio Pulse from AJ Fabino

August 24, 2023 | 6:48 pm

EXEL

NVS

Exelixis Inc's (EXEL) phase 3 CABINET pivotal trial for its lead cancer treatment, Cabometyx, has been recommended to stop early due to significant improvement in efficacy. The trial was evaluating Cabometyx against a placebo in patients with advanced pancreatic neuroendocrine tumors. William Blair analysts have reiterated their Outperform rating for EXEL, despite uncertainties surrounding the market exclusivity of Cabometyx, which is projected until 2030.

Portfolio Pulse from Vandana Singh

August 24, 2023 | 6:46 pm

HOWL

Wedbush analysts initiated coverage on Werewolf Therapeutics Inc (NASDAQ:HOWL) with an Outperform rating and a price target of $9. They believe the company's INDUKINE technology, which leverages its proprietary PREDATOR platform for solid tumors, is underappreciated by the market. The analysts see an attractive risk/reward ahead of initial clinical data from lead asset WTX-124, currently in Phase 1 study, in 4Q 2023. As of June 30, 2023, the company had cash and cash equivalents of $137.5 million.

Portfolio Pulse from Vandana Singh

August 24, 2023 | 6:43 pm

AI

NVDA

Tech and AI stocks are trading lower as the sector pulls back after surging ahead of NVIDIA's Wednesday earnings reports.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 6:43 pm

DIS

Disney shares are trading lower due to overall market weakness and the ongoing SAG-AFTRA strike.

Portfolio Pulse from Benzinga Newsdesk

August 24, 2023 | 6:36 pm

SWTX

SpringWorks Therapeutics Inc (NASDAQ:SWTX) received a Form 483 letter from the FDA in March due to a failure in the analysis of an exploratory endpoint in the Phase 3 DeFi trial. However, the company corrected the analysis and the FDA has completed all required inspections. Analysts from HC Wainwright continue to view nirogacestat as the standard-of-care regimen for treating desmoid tumors and expect it to receive FDA approval. They reiterated a Buy rating for SWTX with a price target of $66.

Portfolio Pulse from Vandana Singh

August 24, 2023 | 6:35 pm

ENPH

Enphase Energy, Inc. (NASDAQ:ENPH) shares are trading lower, following a rough month for solar-related stocks. The drop is attributed to weak third-quarter revenue guidance from both Enphase and SolarEdge, and poor preliminary second-quarter results from Sunpower. Keybanc analyst Sophie Karp maintained Enphase Energy with an Overweight but lowered the price target from $267 to $200.

Portfolio Pulse from Ryan Gustafson

August 24, 2023 | 6:34 pm

DG

A significant bearish stance has been taken on Dollar General (NYSE:DG) as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 39% bullish and 60% bearish. The price of DG is down -3.19% at $153.46, and RSI indicators suggest that the stock may be oversold. Next earnings are expected to be released in 7 days.

Portfolio Pulse from Benzinga Insights

August 24, 2023 | 6:33 pm

TIVC

Tivic Health Systems (NASDAQ:TIVC) stock is trading lower by 8.5% after the company announced a 1-for-100 reverse stock split. The move is aimed at complying with Nasdaq listing requirements as the company faced delisting due to low stock price. The reverse split is expected to restore compliance and maintain the company's Nasdaq listing.

Portfolio Pulse from Henry Khederian

August 24, 2023 | 6:32 pm

NVDA

PLTR

Shares of Palantir Technologies Inc (NYSE:PLTR) are trading lower by approximately 6.37% amid broader tech sector weakness. The company's shares initially traded higher in sympathy with NVIDIA, which reported strong Q2 financial results and Q3 guidance. Palantir, known for its AI-driven data analytics platforms, could potentially benefit from NVIDIA's robust AI performance. NVIDIA's success might indicate improved data analytics capabilities, leading to increased demand for Palantir's platforms and services.

Portfolio Pulse from Henry Khederian

August 24, 2023 | 6:31 pm